Department of pharmacy, Yuhuangding Hospital, Yantai, China.
Department of Hepatobiliary Surgery, Affiliated 1st Hospital of Dalian Medical University, No.222, Zhongshan Road, Dalian, China.
Biomed Pharmacother. 2018 Jul;103:1187-1193. doi: 10.1016/j.biopha.2018.04.128. Epub 2018 May 7.
Hepatocellular carcinoma (HCC) is one of the common malignant cancer worldwide, and its molecular pathogenesis remains elusive and recently long non-coding RNAs (lncRNAs) have been reported that play divergent roles in HCC tumorigenesis and development. In current study, we found a lncRNA, CRNDE is more commonly up-regulated in HCC malignant tissues and associated with poor clinical outcomes. Furthermore, both loss- and gain-functions assays revealed that CRNDE promotes HCC cell proliferation and growth in vitro and in vivo. In addition, we found that CRNDE regulates PI3K/Akt/GSK3β-Wnt/β-catenin axis to exert its oncogenic role in HCC cell proliferation and growth. In conclusion, our findings enlarged our knowledge in the roles of lncRNAs in the progression of HCC and CRNDE as a lncRNA could be a novel target for HCC treatment.
肝细胞癌 (HCC) 是全球常见的恶性肿瘤之一,其分子发病机制仍不清楚,最近有研究报道长链非编码 RNA (lncRNA) 在 HCC 肿瘤发生和发展中发挥着不同的作用。在本研究中,我们发现 lncRNA CRNDE 在 HCC 恶性组织中更为常见,与不良的临床结局相关。此外,通过缺失和获得功能实验发现,CRNDE 可促进 HCC 细胞在体外和体内的增殖和生长。此外,我们发现 CRNDE 通过调节 PI3K/Akt/GSK3β-Wnt/β-catenin 轴发挥其在 HCC 细胞增殖和生长中的致癌作用。总之,我们的研究结果扩大了我们对 lncRNA 在 HCC 进展中作用的认识,CRNDE 作为 lncRNA 可能成为 HCC 治疗的新靶点。